论文部分内容阅读
本试验采用犬细小病毒单克隆抗体（ＣａｎｉｎｅＰａｒｖｏｖｉｒｕｓＭｏｎｏｃｌｏｎａｌＡｎｔｉｂｏｄｙ，ＣＰＶＭｃＡｂ）对２８７例患细小病毒性肠炎的病犬，经股内侧肌肉注射进行治疗，取得令人满意的结果。１．在收治的２８７例病犬中，治愈２７９例，治愈率高达９７．２１％，尤其是小于３月龄的幼犬，治愈率高达９７．９２％，显著高于其他治疗方法的治疗效果。２．在收冶的２８７例病犬中，６月龄以下幼犬占９３．７３％。冬季发病犬占９２．６８％，说明本病主要发生于６月龄以下幼犬，冬季发病较多，其次为初春或深秋，夏季发病较少。３．在临床治疗中发现，发病一天的病犬仅注射ＣＰＶＭｃＡｂ，而不采取其他对症措施，病犬即可在２天内完全康复。发病３天以内的病犬２４１只，在注射ＣＰＶＭ＿－ｃＡｂ同时，结合对症措施，治愈２４Ｏ只，仅死亡１只。随病程延长，治愈率下降。另外，８８．５３％的治愈犬在注射ＣＰＶＭｃＡｂ４天内完全康复，说明采用ＣＰＶＭｃＡｂ治疗还可缩短病程。４，注射ＣＰＶＭｃＡｂ后７ｈ以内死亡的病犬，主要是由于发病后期，全身性衰竭、肠道广泛性出血、坏死和严重脱水，注射的ＣＰＶＭｃＡｂ未能起作用。３天后死亡的病犬，可能是由于ＣＰＶＭｃＡｂ虽?
In this study, Canine Parvovirus Monoclonal Antibody (CPVMcAb) was used to treat 287 dogs with parvovirus enteritis via the intramuscular injection of intramuscular medulla to achieve satisfactory results. 1. Among the 287 dogs treated, 279 cases were cured, the cure rate was as high as 97.21%, especially for puppies less than 3 months old, the cure rate was as high as 97.92%, which was significantly higher than that of other treatment methods. 2. In the collection of 287 cases of dogs, puppies less than 6 months accounted for 93.73%. The number of dogs in winter accounted for 92.68%, indicating that the disease occurs mainly in puppies 6 months old, more incidence in winter, followed by early spring or late autumn, less incidence in summer. 3. In clinical treatment found that the incidence of the day dog only CPVMcAb injection, without taking other symptomatic measures, dogs can be completely recovered within 2 days. 241 cases of sick dogs within 3 days of onset, in the injection of CPVM_-cAb at the same time, with symptomatic measures, healing 24O only one death. With the extended duration, the cure rate decreased. In addition, 88.53% of cures completely recovered within 4 days of CPVMcAb injection, indicating that treatment with CPVMcAb can also shorten the course of the disease. 4, CPVMcAb within 7h after the death of dogs, mainly due to late onset, systemic failure, extensive intestinal bleeding, necrosis and severe dehydration, injection of CPVMcAb failed to play a role. Dogs died after 3 days may be due to CPVMcAb Although?